Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Kopran Limited ( (IN:KOPRAN) ).
Kopran Limited has announced the closure of its trading window for directors, designated persons and their immediate relatives from 1 April 2026 until 48 hours after the declaration of its audited financial results for the fourth quarter and full year ended 31 March 2026. The move, taken in line with SEBI’s insider trading regulations and the company’s internal disclosure code, signals the upcoming release of financial results and reinforces governance controls around unpublished price-sensitive information for market participants.
More about Kopran Limited
Kopran Limited is an Indian pharmaceutical company engaged in manufacturing and marketing bulk drugs and finished dosage formulations. The company focuses on supplying pharmaceutical products from its facilities in Maharashtra, serving domestic and international markets through its operations and listings on BSE and NSE.
Average Trading Volume: 18,756
Technical Sentiment Signal: Sell
Current Market Cap: 5.73B INR
See more data about KOPRAN stock on TipRanks’ Stock Analysis page.